Recent Patent Oppositions in the Pharmaceutical Industry
The European Patent Office (EPO) receives more than 2000 oppositions each year, directly impacting the future success and exclusivity of pharmaceutical products. Monitoring the outcomes of these oppositions is crucial as it assists in developing effective strategies for launching generic versions of drugs. Moreover, it aids in identifying competitors that may be eating into market […]
Understanding the Farxiga®/Forxiga® Patent Thicket: What’s Changing in 2025
While numerous drugs for diabetes are available in the market, many come with undesirable side effects such as weight gain, hypoglycemia, and hypertension. However, a game-changing solution has been introduced in the form of Farxiga®/Forxiga®. Farxiga®/Forxiga® is the trade name for Dapagliflozin, by AstraZeneca. It is a sodium-glucose cotransporter 2 (SGLT2) inhibitor, representing a novel […]
73 Drugs Losing Europe Exclusivity in 2024
In Europe, 2024 marks the year when exclusivity for a diverse range of drugs encompassing various therapeutic categories is set to expire. This includes established medications like Cabometyx and Zavicefta and breakthrough treatments like Tagrisso. The article provides a list of 73 such drug patents across diverse therapeutic categories, ranging from antivirals to antineoplastics, reflecting […]
Dolby’s Strategy to Double Versatile Video Coding Standard Patent Licensing Returns
Streaming crystal-clear 8K content on a phone without buffering, even on unreliable internet, is no longer a far-fetched thought. This seemingly magical experience relies heavily on the intricate video compression technologies developed by industry leaders like Dolby and JVC Kenwood. Although this is commonly known, these companies are being highlighted in this case study for […]
8 Months In, the Unitary Patent & Court: Unmasking Industry Reactions & Shaping Your Next Move
In the eight months since its introduction, the Unitary Patent System has initiated a significant transformation in the field of patent law within the European Union. This article aims to offer an insightful overview of the Unitary Patent and Unified Patent Court, shedding light on how this system benefits various sectors, the notable cases that […]
4 Plant-based innovations that make dairy-free products consumer acceptable
Even as customers’ demand for dairy-free products grows, sales of most plant-based products have sharply declined over the past year. One of the primary reasons consumers reject plant-based foods is that their taste is too different from what they’re used to. Source: https://www.fmi.org As a result, innovating in this space has become more like a […]
Arthritis Drug Patents Expiring 2024 – 2028
The arthritis treatment industry is characterized by its intense competitiveness, driving companies to invest significantly in research and development to secure leading arthritis drug patents. Consequently, the expiration of patents for this disease creates significant opportunities for companies specializing in generic medications. A notable example of the market dynamics in this industry is the case […]
5 Important Patent Portfolio Valuation Checks To Make Your Portfolio An Asset
Acquiring multiple patents over time will result in a portfolio that may or may not align with a company’s objectives, values, and goals. Therefore, to ensure a stronger, more relevant portfolio, it’s important to conduct a successful patent portfolio valuation, which involves a crucial step: relevancy checking. The primary objective of relevancy checking is to […]
Confirming Product Overlap in Patent Infringement Analysis with Limited Online Resources
The standard approach to prove product overlap during patent infringement analysis involves researching online resources such as product manuals, datasheets, and FAQs. However, online literature won’t always provide conclusive evidence for technology overlap in certain high-tech sectors such as LiDAR (Light Detection and ranging) and semiconductors. This issue is compounded by the complexity of the […]
Top 13 AI-based Patent Search Databases for your Patent Search Needs
AI (Artificial Intelligence) has transformed intellectual property (IP) by reducing human effort and enabling patent experts to refine how they discover, analyze, and leverage intellectual property. It’s no surprise that a Google search for AI-based patent search databases will yield hundreds, if not thousands, of platforms available at your disposal. To make your search for […]
3 Patent Licensing Pitfalls You Can’t Afford to Miss
Exploring additional revenue streams beyond the primary product line is a common goal for many companies. However, the monetization department often encounters numerous obstacles when venturing into licensing patents. Initially, the inertia can be significant. While written guidelines are readily available online, they only provide a superficial understanding of the process. The complexities and nuances […]
Patent Pruning – Stop missing out on lucrative licensing opportunities
It is not uncommon for companies to engage in aggressive patent pruning due to budgetary constraints. However, what if one could analyze the licensing potential of these patents before the patent pruning process? This article introduces the cons of a half-baked patent pruning strategy by studying the patents pruned by three companies from distinct sectors. […]
The Mounjaro Patent Thicket: Patents expiring in 2036
More than 500 million people around the world are affected by diabetes, and this issue is intensified by a surging obesity crisis, particularly in wealthier nations. In such a crisis, drugs like Mounjaro represent a highly lucrative opportunity for generic drugmakers to address the escalating medical demand on a global scale. For reference, here is […]
Cancer Drug Patents Expiring 2024-2028
The fiercely competitive nature of the oncology industry makes the companies invest heavily in research and development to bring in top cancer-treating drug patents. Consequently, the expiration of patents for cancer drugs creates significant opportunities for companies specializing in generic medications. Identifying these patents can help enterprises expand and diversify their generic drug portfolios. This […]
Patent Marking – The smartest strategy to shortlist high-value patents from a large set
When Nick, a legal counsel representing a major Non-Practicing Entity (NPE) in the United States, approached us, his goal was to acquire 200 patents from a portfolio of 1000 within a strict two-month timeframe. It became evident that conventional manual methods would fall short of meeting this challenging deadline. To provide some context, it meant […]
30 Diabetes Drug Patents Expiring from 2024 till 2028 – GreyB
Given the competitive nature of the pharmaceutical domain, the expiration of drug patents presents significant opportunities, particularly for companies specializing in generic medications. Pharmaceutical companies seeking to expand or diversify their generic drug portfolios would find this list of great value in identifying diabetes drug patents that will expire between 2024 and 2028. By utilizing […]